BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22186766)

  • 1. Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy.
    Yu Q; Zhang X; Ji C; Yang H; Gao M; Hong S; Hu G
    Eur Arch Otorhinolaryngol; 2012 Sep; 269(9):2103-9. PubMed ID: 22186766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival analysis for laryngeal carcinoma patients with no surgery, radiotherapy or chemotherapy].
    Yu Q; Hu GH; Zhang XY; Ji CY; Yang H; Gao MH; Hong SL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Feb; 46(2):123-7. PubMed ID: 21426706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
    Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma.
    Jin T; Hu WH; Guo LB; Chen WK; Li QL; Lin H; Cai XY; Ge N; Sun R; Bu SY; Zhang X; Qiu MY; Zhang W; Luo S; Zhou YX
    Chin J Cancer; 2011 Jul; 30(7):482-9. PubMed ID: 21718594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
    Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
    Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
    PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
    Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
    Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
    Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Graboyes EM; Zhan KY; Garrett-Mayer E; Lentsch EJ; Sharma AK; Day TA
    Cancer; 2017 Jun; 123(12):2248-2257. PubMed ID: 28182267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of relevant factors causing postoperative recurrence of laryngeal cancer after partial laryngectomy].
    Liu C; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):377-81. PubMed ID: 24054016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of HAX-1 expression in laryngeal carcinoma.
    You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
    Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
    Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
    Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
    Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connexin 43 (Cx43) Expression in Laryngeal Squamous Cell Carcinomas: Preliminary Data on Its Possible Prognostic Role.
    Puzzo L; Caltabiano R; Parenti R; Trapasso S; Allegra E
    Head Neck Pathol; 2016 Sep; 10(3):292-7. PubMed ID: 26748803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
    Wolf GT; Bellile E; Eisbruch A; Urba S; Bradford CR; Peterson L; Prince ME; Teknos TN; Chepeha DB; Hogikyan ND; McLean SA; Moyer J; Taylor JMG; Worden FP
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):355-366. PubMed ID: 28152117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.